Crossmark

Consenso multidisciplinar español sobre las características de los pacientes con asma grave en tratamiento con biológicos susceptibles de pasar a tratamiento domiciliario

Crossref DOI link: https://doi.org/10.1016/j.rce.2022.11.008

Published Print: 2023-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cisneros-Serrano, C.

Rial, M.J.

Gómez-Bastero-Fernández, A.

Igea, J.M.

Martínez-Meca, A.

Fernández-Lisón, L.C.

López-Carrasco, V.

Villamañán-Bueno, E.

Plá-Martí, M.J.

Chiner, E.
Funding

Funding for this research was provided by:

GlaxoSmithKline
License Information

Text and Data Mining valid from 2023-03-01

stm-asf valid from 2023-03-01

stm-asf valid from 2023-03-01

stm-asf valid from 2023-03-01

stm-asf valid from 2023-03-01

stm-asf valid from 2023-03-01
More Information

This article is maintained by: Elsevier

Article Title: Consenso multidisciplinar español sobre las características de los pacientes con asma grave en tratamiento con biológicos susceptibles de pasar a tratamiento domiciliario

Journal Title: Revista Clínica Española

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rce.2022.11.008

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below